Bausch + Lomb Corporation (NYSE:BLCO) Q3 2025 Earnings Call Transcript
Bausch + Lomb Corporation (NYSE:BLCO) Q3 2025 Earnings Call Transcript October 29, 2025Bausch + Lomb Corporation misses on earnings expectations.
Bausch & Lomb Corp (BLCO)
Market is closed
Sector: Ophthalmic Goods
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Icahn Capital LP Carl Icahn | 3,500,000 | $45,535,000 | 0.58% | |
| 2. | D E Shaw D. E. Shaw | 2,607,000 | $33,917,070 | +39% | 0.02% |
| 3. | GoldenTree Asset Management Steven Tananbaum | 2,583,185 | $33,523,801 | +15% | 3.24% |
| 4. | Oaktree Capital Management Howard Marks | 2,521,245 | $32,801,397 | 0.56% | |
| 5. | Glenview Capital Larry Robbins | 1,553,855 | $20,215,654 | +211% | 0.57% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.28 | 22,000 | $248,072.00 | 719,156 | 2025-05-22 | Filing | |
| $11.76 | 1,695 | $19,924.73 | 41,748 | 2025-05-02 | Filing | |
| $15.66 | 32,250 | $505,067.25 | 595,169 | 2024-08-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.06 | 4,550,357 | $77,606,338.64 | 310,449,643 | 2022-06-01 | Filing | |
| $17.06 | 35,000,000 | $596,925,000.00 | 315,000,000 | 2022-05-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,429 | $262,655 | 0.03% | |
| 2. | 14,300 | $215,501 | 0% | |
| 3. | 116,000 | $121,066 | 0% | |
| 4. | 1,138 | $16,356 | 0% | |
| 5. | 370 | $5,576 | 0% |
News See All
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Bausch + Lomb's Second Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
Barclays lowered its price target on Bausch & Lomb (NYSE: BLCO) from $19 to $16 on June 6, maintaining an Equalweight rating.
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Bausch + Lomb's First Quarter 2025 Earnings Call. All participants will be in listen-only mode.
10 Most Undervalued Canadian Stocks to Buy According to Wall Street Analysts
As February was concluding, Reuters reported that Canada's economy showed unexpected strength in Q4 2024, with an annualized growth rate of 2.6%.
Bausch + Lomb Corporation (NYSE:BLCO) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the Bausch + Lomb Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
Bausch & Lomb Corporation (BLCO)-A Bull Case Theory
In this article, we’ll summarize a bullish thesis posted on VIC covering Bausch & Lomb Corporation (BLCO) in late July when BLCO stock was trading at $15.83.
Bausch + Lomb Corporation (NYSE:BLCO) Q3 2024 Earnings Call Transcript
Operator: Good morning and welcome to Bausch + Lomb's Third Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Bausch + Lomb’s Second Quarter 2024 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
